OPPO-WATCHNCT07912671
Out-Patient Proactive Observation With Wearable-Assisted Tracking for Cardiovascular Health Management
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Secondary (40)
Show 35 moreShow less
Arms and interventions
Participants receive wearable device-based, LE8-guided management with access to their monitoring data, health and medication reminders, and individualized LE8 score feedback, together with routine in-person cardiology outpatient follow-up every three months for 12 months.
Participants wear a smartwatch for data collection but do not have access to monitoring data, health or medication reminders, or Life's Essential 8 (LE8) score feedback. They receive routine in-person cardiology outpatient follow-up every three months for 12 months.
Devices: Wearable Device-Based Monitoring and LE8 Feedback
Other: Routine Outpatient Care With Data-Blinded Wearable Monitoring
Sites
1 site in 1 country
- Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing, China